Literature DB >> 10710942

Relationship between pernicious anaemia and gastric neuroendocrine cell disorders.

A M Spoelstra-de Man1, S S Wagenaar, A van der Sluys Veer, C B Brouwer.   

Abstract

The incidence of gastric carcinoid tumours is increasing. This rise is probably due to the number of gastroscopies and improved histological techniques. The majority (65%) of these gastric tumours is associated with chronic atrophic gastritis and pernicious anaemia. In this article two patients are presented, one with pernicious anaemia and gastric neuroendocrine cell hyperplasia and one with pernicious anaemia and multiple gastric carcinoids. These neuroendocrine cell disorders have a relatively favourable prognosis. Therefore, a wait-and-see policy was preferred. The pathogenesis, clinical symptoms, diagnosis, prognosis and treatment of these different neuroendocrine cell manifestations are discussed. We recommend performing a gastroscopy at the time of diagnosis for young patients with pernicious anaemia, and whenever abdominal problems, unexplained weight loss or aggravation of the anaemia arise.

Entities:  

Mesh:

Year:  2000        PMID: 10710942     DOI: 10.1016/s0300-2977(99)00117-5

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  3 in total

1.  Treatment of solitary gastric carcinoid tumor by endoscopic polypectomy in a patient with pernicious anemia.

Authors:  Gurhan Kadikoylu; Irfan Yavasoglu; Vahit Yukselen; Esra Ozkara; Zahit Bolaman
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

Review 2.  Chronic hypergastrinemia: causes and consequences.

Authors:  Lori A Orlando; Lane Lenard; Roy C Orlando
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

3.  Refractory thrombocytopenia responds to octreotide treatment in a case of evans syndrome with gastric neuroendocrine tumor.

Authors:  Kocfa Chung-Delgado; Alejandro Revilla-Montag; Sonia Guillén-Bravo; Hugo Ríos-Díaz; José C Alva-Muñoz
Journal:  Case Rep Hematol       Date:  2013-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.